-
1
-
-
34248136340
-
Inflammatory bowel disease: Clinical aspects and established and evolving therapies
-
DOI 10.1016/S0140-6736(07)60751-X, PII S014067360760751X
-
Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657 (Pubitemid 46722637)
-
(2007)
Lancet
, vol.369
, pp. 1641-1657
-
-
Baumgart, D.C.1
Sandborn, W.J.2
-
2
-
-
2442563304
-
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
-
DOI 10.1053/j.gastro.2004.01.063
-
Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 (Pubitemid 38649869)
-
(2004)
Gastroenterology
, vol.126
, Issue.6
, pp. 1504-1517
-
-
Loftus Jr., E.V.1
-
3
-
-
44349124113
-
The genetics and immunopathogenesis of inflammatory bowel disease
-
DOI 10.1038/nri2340, PII NRI2340
-
Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008; 8: 458-466 (Pubitemid 351733422)
-
(2008)
Nature Reviews Immunology
, vol.8
, Issue.6
, pp. 458-466
-
-
Cho, J.H.1
-
5
-
-
55949124035
-
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
-
Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008 105: 16731-16736
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 16731-16736
-
-
Sokol, H.1
Pigneur, B.2
Watterlot, L.3
-
6
-
-
34447101563
-
Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.
-
Moehle C, Ackermann N, Langmann T, et al. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.; J Mol Med 2006 84: 1055-1066
-
(2006)
J Mol Med
, vol.84
, pp. 1055-1066
-
-
Moehle, C.1
Ackermann, N.2
Langmann, T.3
-
7
-
-
15844389604
-
Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer
-
Hill KA, Wang KL, Stryker SJ, et al. Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer. Oncol Rep 2004 11: 951-956
-
(2004)
Oncol Rep
, vol.11
, pp. 951-956
-
-
Hill, K.A.1
Wang, K.L.2
Stryker, S.J.3
-
9
-
-
69449105914
-
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.
-
Smith AM, Rahman FZ, Hayee B, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.; Exp Med 2009 206: 1883-1897
-
(2009)
Exp Med
, vol.206
, pp. 1883-1897
-
-
Smith, A.M.1
Rahman, F.Z.2
Hayee, B.3
-
10
-
-
34248136828
-
Inflammatory bowel disease: Cause and immunobiology
-
DOI 10.1016/S0140-6736(07)60750-8, PII S0140673607607508
-
Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-1640 (Pubitemid 46722636)
-
(2007)
Lancet
, vol.369
, pp. 1627-1640
-
-
Baumgart, D.C.1
Carding, S.R.2
-
11
-
-
22344448660
-
Characteristics of intestinal dendritic cells in inflammatory bowel diseases
-
DOI 10.1053/j.gastro.2005.05.013, PII S0016508505008838
-
Hart AL, Al-Hassi HO, Rigby RJ, et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005; 129: 50-65. (Pubitemid 41002042)
-
(2005)
Gastroenterology
, vol.129
, Issue.1
, pp. 50-65
-
-
Hart, A.L.1
Al-Hassi, H.O.2
Rigby, R.J.3
Bell, S.J.4
Emmanuel, A.V.5
Knight, S.C.6
Kamm, M.A.7
Stagg, A.J.8
-
12
-
-
0034445697
-
Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
-
DOI 10.1128/IAI.68.12.7010-7017.2000
-
Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010-7017 (Pubitemid 32463415)
-
(2000)
Infection and Immunity
, vol.68
, Issue.12
, pp. 7010-7017
-
-
Cario, E.1
Podolsky, D.K.2
-
13
-
-
13244277880
-
Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing
-
DOI 10.1126/science.1103685
-
Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-lβ processing. Science 2005; 307: 734-738 (Pubitemid 40194645)
-
(2005)
Science
, vol.307
, pp. 734-738
-
-
Maeda, S.1
Hsu, L.-C.2
Liu, H.3
Bankston, L.A.4
Iimura, M.5
Kagnoff, M.F.6
Eckmann, L.7
Karin, M.8
-
14
-
-
4444253690
-
NOD2 is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses
-
DOI 10.1038/ni1092
-
Watanabe T, Kitani A, Murray PJ, Strober W. N0D2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800-808 (Pubitemid 39172973)
-
(2004)
Nature Immunology
, vol.5
, Issue.8
, pp. 800-808
-
-
Watanabe, T.1
Kitani, A.2
Murray, P.J.3
Strober, W.4
-
15
-
-
0037458665
-
Host recognition of bacterial muramyl dipeptide mediated through NOD2: Implications for Crohn's disease
-
DOI 10.1074/jbc.C200673200
-
Inohara N, Ogura y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through N0D2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509-5512 (Pubitemid 36800790)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.8
, pp. 5509-5512
-
-
Inohara, N.1
Ogura, Y.2
Fontalba, A.3
Gutierrez, O.4
Pons, F.5
Crespo, J.6
Fukase, K.7
Inamura, S.8
Kusumoto, S.9
Hashimoto, M.10
Foster, S.J.11
Moran, A.P.12
Fernandez-Luna, J.L.13
Nunez, G.14
-
16
-
-
0346463319
-
The Th1 immune pathway as a therapeutic target in Crohn's disease
-
Bamias G, Sugawara K, Pagnini C, Cominelli F. The Thl immune pathway as a therapeutic target in Crohn's disease. Curr Opin Investig Drugs 2003; 4: 1279-1286 (Pubitemid 38100572)
-
(2003)
Current Opinion in Investigational Drugs
, vol.4
, Issue.11
, pp. 1279-1286
-
-
Bamias, G.1
Sugawara, K.2
Pagnini, C.3
Cominelli, F.4
-
17
-
-
23344446340
-
Defects in mucosal immunity leading to ulcerative colitis
-
DOI 10.1111/j.0105-2896.2005.00286.x
-
Targan SR, Karp LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 2005; 206: 296-305. (Pubitemid 41105177)
-
(2005)
Immunological Reviews
, vol.206
, pp. 296-305
-
-
Targan, S.R.1
Karp, L.C.2
-
18
-
-
0037216498
-
Increased expression of interleukin 17 in inflammatory bowel disease
-
DOI 10.1136/gut.52.1.65
-
Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70. (Pubitemid 36020767)
-
(2003)
Gut
, vol.52
, Issue.1
, pp. 65-70
-
-
Fujino, S.1
Andoh, A.2
Bamba, S.3
Ogawa, A.4
Hata, K.5
Araki, Y.6
Bamba, T.7
Fujiyama, Y.8
-
19
-
-
57149091150
-
Les cellules Th17 Une nouvelle population de cellules T CD4 effectrices pro-inflammatoires
-
Leung-Theung-Long S, Guerder S. Les cellules Th17: une nouvelle population de cellules T CD4 effectrices pro-inflammatoires. Med Sci (Paris) 2008; 24: 972-976 (Pubitemid 352772929)
-
(2008)
Medecine/Sciences
, vol.24
, Issue.11
, pp. 972-976
-
-
Leung-Theung-Long, S.1
Guerder, S.2
-
20
-
-
33947540822
-
L'IL-23R, un nouveau gène de susceptibilité dans les maladies inflammatoires chroniques intestinales
-
Peyrin-Biroulet L, Parmentier-Decrucq E, Branche J, Desreumaux P. L'IL-23R, un nouveau gène de susceptibilité dans les maladies inflammatoires chroniques intestinales. Med Sci (Paris) 2007; 23: 250-252 (Pubitemid 46472644)
-
(2007)
Medecine/Sciences
, vol.23
, Issue.3
, pp. 250-252
-
-
Peyrin-Biroulet, L.1
Parmentier-Decrucq, E.2
Branche, J.3
Desreumaux, P.4
-
21
-
-
37549030879
-
Lnterleukin-17 as an effector molecule of innate and acquired immunity against infections
-
Matsuzaki G, Umemura M. lnterleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007 51: 1139-1147
-
(2007)
Microbiol Immunol
, vol.51
, pp. 1139-1147
-
-
Matsuzaki, G.1
Umemura, M.2
-
22
-
-
33646577466
-
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
-
Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441: 235-238
-
(2006)
Nature
, vol.441
, pp. 235-238
-
-
Bettelli, E.1
Carrier, Y.2
Gao, W.3
-
23
-
-
43049085167
-
Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: Future therapeutic targets
-
Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol 2008 585: 361-374
-
(2008)
Eur J Pharmacol
, vol.585
, pp. 361-374
-
-
Kraneveld, A.D.1
Rijnierse, A.2
Nijkamp, F.P.3
Garssen, J.4
-
24
-
-
0013069021
-
Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease
-
DOI 10.1136/gut.52.5.720
-
Keshavarzian A, Banan A, Farhadi A, et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 2003; 52: 720-728 (Pubitemid 36528876)
-
(2003)
Gut
, vol.52
, Issue.5
, pp. 720-728
-
-
Keshavarzian, A.1
Banan, A.2
Farhadi, A.3
Komanduri, S.4
Mutlu, E.5
Zhang, Y.6
Fields, J.Z.7
-
25
-
-
47949116890
-
Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease
-
Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis 2008 14: 1000-1011
-
(2008)
Inflamm Bowel Dis
, vol.14
, pp. 1000-1011
-
-
Zimmerman, N.P.1
Vongsa, R.A.2
Wendt, M.K.3
Dwinell, M.B.4
-
27
-
-
39049142086
-
IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin
-
Adams RJ, Heazlewood SP, Gilshenan KS, et al. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin. Am J Gastroenterol 2008 103: 386-396
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 386-396
-
-
Adams, R.J.1
Heazlewood, S.P.2
Gilshenan, K.S.3
-
28
-
-
66849097828
-
Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease
-
Sendid B, Jouault T, Vitse A, et al. Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease. Med Sci (Paris) 2009 25: 473-481
-
(2009)
Med Sci (Paris)
, vol.25
, pp. 473-481
-
-
Sendid, B.1
Jouault, T.2
Vitse, A.3
-
29
-
-
84969213492
-
Wellcome trust case control consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
-
Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447: 661-678
-
(2007)
Nature
, vol.447
, pp. 661-678
-
-
|